GPRC5A: A Potential Drug Target and Biomarker (G9052)

Target Name: GPRC5A

NCBI ID: G9052

GPRC5A

GPRC5A: A Potential Drug Target and Biomarker

G protein-coupled receptors (GPCRs) are a family of transmembrane proteins that play a crucial role in cellular signaling. GPCRs are involved in various physiological processes, including sensory perception, neurotransmission, and hormone signaling. GPRC5A, a GPCR gene, has been identified as a potential drug target and biomarker.

GPRC5A is a 19-kDa transmembrane protein that is expressed in various tissues, including brain, heart, and peripheral tissues. GPRC5A is a GPCR that is known to play a role in the regulation of neural plasticity and drug addiction. GPRC5A has been shown to be involved in the regulation of neurotransmitter release, cell survival, and neurotransmission.

GPRC5A is a good candidate for a drug target because of its unique structure and its involvement in cellular signaling. GPRC5A has a unique extracellular domain that is characterized by a long amino acid sequence that is involved in the formation of a hydrophobic patch. This domain is known as the N-terminal transmembrane region (NTM) and is responsible for the stability and localization of GPRC5A in the membrane.

GPRC5A is also involved in the regulation of drug addiction. Studies have shown that GPRC5A is involved in the regulation of dopamine release and that it may play a role in the development of drug addiction. GPRC5A has also been shown to be involved in the regulation of Nicotine and opium were beaten.

In addition to its potential role in drug addiction, GPRC5A is also a good candidate for a biomarker. GPRC5A has been shown to be involved in the regulation of neurotransmission and has been used as a marker for various neurological disorders, including depression, anxiety, and Alzheimer's disease.

GPRC5A has also been shown to be involved in the regulation of pain perception. Studies have shown that GPRC5A is involved in the regulation of nociceptive pain and that it may play a role in the development of chronic pain.

In conclusion, GPRC5A is a unique GPCR that is involved in the regulation of various physiological processes. Its unique structure and its involvement in drug addiction, neurotransmission, and pain perception make it a promising candidate for a drug target and biomarker. Further research is needed to fully understand the role of GPRC5A in cellular signaling and its potential as a drug target and biomarker.

Protein Name: G Protein-coupled Receptor Class C Group 5 Member A

Functions: Orphan receptor. Could be involved in modulating differentiation and maintaining homeostasis of epithelial cells. This retinoic acid-inducible GPCR provide evidence for a possible interaction between retinoid and G-protein signaling pathways. Functions as a negative modulator of EGFR signaling (By similarity). May act as a lung tumor suppressor (PubMed:18000218)

The "GPRC5A Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GPRC5A comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets